It's unusual for a medication to become a household name; even more uncommon for its branding to become, like Advil, shorthand for an entire class of products; and rarest of all, for it to change not just U.S. medicine, but U.S. culture. Ozempic has done all three.
Approved in 2017 as a Type 2 diabetes medication, Ozempic has largely made its name and a fortune for its manufacturer, Novo Nordisk-as a weight-loss aid. Its runaway success mirrors that of similar medications, including Eli Lilly's Mounjaro and Wegovy, another Novo Nordisk product and the only one in the trio technically approved for weight loss. Prescriptions for all of them are flying off the pad at an eye-popping rate: they're up 300% since early 2020, with more than 9 million written in the U.S. in the last three months of 2022 alone, according to health-care-industry research firm Trilliant Health. Demand is so great that there have been shortages of all three drugs, with some diabetes patients struggling to fill their prescriptions as they compete for limited supplies.
Plenty of physicians (and pharmaceutical executives who stand to get very, very rich) say this frenzy is a good thing, given that roughly three-quarters of U.S. adults qualify as either overweight or obese and are thus, according to leading public-health authorities, at risk of a range of serious health complications. "Obesity is an epidemic, and we urgently need effective treatments," says Dr. Sahar Takkouche, an obesity and bariatric medicine specialist at Vanderbilt Health. But others are uneasy about the age of Ozempic, which can feel like a return to an era when thinness was unquestioningly valued.
Denne historien er fra November 20, 2023-utgaven av Time.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra November 20, 2023-utgaven av Time.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Gaza's Doctors Face a New Fight - Polio has resurfaced in Gaza for the first time in 25 years, with the first case confirmed Aug. 16 in a 10-month-old unvaccinated child in Deir al-Balah, the enclave's health authorities said;
Polio has resurfaced in Gaza for the first time in 25 years, with the first case confirmed Aug. 16 in a 10-month-old unvaccinated child in Deir al-Balah, the enclave's health authorities said; the World Health Organization (WHO) announced in July that the virus had been initially detected in wastewater in the city.
Justin Theroux The Emmy-winning actor, writer, and producer on Beetlejuice Beetlejuice, his roles in cult classics, and the enduring love for The Leftovers
I was absolutely a fan.
An adaptation of Three Women makes four a crowd
FOR A WORK OF LITERARY NONFICTION TO thrill readers the way Lisa Taddeo's 2019 best seller Three Women has done, it must offer more than just rich subject matter.
3 sisters and one empty recliner
DEATH CAN BOTH TEAR FAMILY MEMBERS apart and bind them closer-often simultaneously.
NATASHA ROTHWELL OUT FRONT
The creator-performer moves from beloved supporting roles to center stage in a deeply personal new comedy series
STILL PROCESSING
Not all ultra-processed foods are the same. Or, some argue, even unhealthy
IRON FIST
A crackdown on El Salvador’s gangs made Nayib Bukele one of the world’s most popular leaders. Is he going too far?
Long-distance relationships aren't just for romance
NURTURING LONG-DISTANCE friendships takes work, but the payoff is worth it-and even small gestures can keep bonds alive.
HOW TO KNOW IF YOUR DYNAMIC IS TOXIC AND WHAT TO DO ABOUT IT
Friends can be great-until they're not.
It's never too late to make new friends
CHRIS DUFFY ISN'T GOING TO SUGARcoat it: making friends as an adult is hard.